Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Serono reports second quarter earnings

Serono (SWX:SEO; SRA) reported second quarter earnings per ADS of $0.22, up 29%

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE